NCT06120595View on ClinicalTrials.gov

Intervention Study Based on Real-world Data to Improve Quality of Life After Breast Cancer Treatment, the REBECCA-2 Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

November 1, 2023

Study Completion Date

May 1, 2025

Conditions
Cancer Related Fatigue
Interventions
DRUG

REBECCA-assisted intervention 1

The intervention will include changes in medication (e.g. change from Letrozol to Tamoxifen, treatment for polyneuropathy, osteoporosis).

BEHAVIORAL

REBECCA-assisted intervention 2

The intervention will include dietary advice, to a psychologist/psychiatrist and/or personal training with a physiotherapist at 'Pusterommet' (SUH).

OTHER

Standard follow-up

Standard follow-up

Trial Locations (1)

4067

Stavanger University Hospital, Stavanger

All Listed Sponsors
lead

Helse Stavanger HF

OTHER_GOV